Yichang HEC Changjiang Pharma Provides Monthly Update on Proposed Merger with Sunshine Lake Pharma

Reuters
06/09
Yichang HEC Changjiang Pharma Provides Monthly Update on Proposed Merger with Sunshine Lake Pharma

Yichang Hec Changjiang Pharmaceutical Co., Ltd. has released a joint announcement with Sunshine Lake Pharma Co., Ltd., providing a monthly update on the proposed merger by absorption. This transaction involves the privatization of Yichang Hec Changjiang Pharmaceutical Co., Ltd. by Sunshine Lake Pharma Co., Ltd. The companies are progressing with the fulfillment of a pre-condition necessary for the merger. Zhang Yingjun, Chairman of Sunshine Lake Pharma, and Tang Xinfa, Chairman of Yichang Hec Changjiang Pharmaceutical, signed off on the announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 09, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10